These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37770911)

  • 1. Assessment of the diagnostic accuracy of Vibrasense compared to a biothesiometer and nerve conduction study for screening diabetic peripheral neuropathy.
    Sharma K N S; Kumar H A
    J Foot Ankle Res; 2023 Sep; 16(1):65. PubMed ID: 37770911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
    Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
    J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative vibration perception threshold in assessing diabetic polyneuropathy: Should the cut-off value be adjusted for Chinese individuals with type 2 diabetes?
    Liu M; Gao Y; Chen DW; Lin S; Wang C; Chen LH; Ran XW
    J Diabetes Investig; 2021 Sep; 12(9):1663-1670. PubMed ID: 33512757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the neurothesiometer and biothesiometer for measuring vibration perception in diabetic patients.
    Young MJ; Every N; Boulton AJ
    Diabetes Res Clin Pract; 1993 May; 20(2):129-31. PubMed ID: 8375265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Glycated Hemoglobin and Vibration Perception Threshold in Diabetic Peripheral Neuropathy.
    Maiya AG; Parameshwar A; Hande M; Nandalike V
    Int J Low Extrem Wounds; 2020 Jun; 19(2):120-124. PubMed ID: 31838926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
    Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
    Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the 128-Hz tuning fork be an alternative to the biothesiometer for diabetic peripheral neuropathy screening? A cross-sectional study in a tertiary hospital in East India.
    Chattopadhyay S; Goswami S; Sengupta N; Baidya A
    BMJ Open; 2024 Jun; 14(6):e082193. PubMed ID: 38862223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Ipswich Touch Test (IpTT) and 10gm-SMWF (10-gm Semmes-Weinstein mono-filament) in Indian population subset with type 2 diabetes mellitus to detect diabetes neuropathy.
    Senthilkumar S; Dasarathan R; Pazhani P; Gaur A; Sakthivadivel V
    Ir J Med Sci; 2023 Dec; 192(6):2793-2799. PubMed ID: 37140765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of biothesiometry to detect neuropathy in children and adolescents with IDDM.
    Davis EA; Jones TW; Walsh P; Byrne GC
    Diabetes Care; 1997 Sep; 20(9):1448-53. PubMed ID: 9283795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vibration perception threshold in diagnosing diabetic peripheral neuropathy by receiver operating characteristic curve].
    Hou Y; Liu S; Zhu T; Zhang H; Liu G; Zhu Y; Chen H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):951-6. PubMed ID: 23000772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement.
    Zografou I; Iliadis F; Sambanis C; Didangelos T
    Curr Vasc Pharmacol; 2020; 18(5):517-522. PubMed ID: 31340739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.
    Olaleye D; Perkins BA; Bril V
    Diabetes Res Clin Pract; 2001 Nov; 54(2):115-28. PubMed ID: 11640995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy.
    Goel A; Shivaprasad C; Kolly A; Sarathi H A V; Atluri S
    PLoS One; 2017; 12(9):e0183973. PubMed ID: 28880907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of ankle reflex as a screening test for diabetic peripheral neuropathy.
    Malik MM; Jindal S; Bansal S; Saxena V; Shukla US
    Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S340-1. PubMed ID: 24251208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy.
    Magri CJ; Calleja N; Buhagiar G; Fava S; Vassallo J
    Postgrad Med J; 2011 Oct; 87(1032):658-63. PubMed ID: 21954032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study.
    Martin CL; Waberski BH; Pop-Busui R; Cleary PA; Catton S; Albers JW; Feldman EL; Herman WH;
    Diabetes Care; 2010 Dec; 33(12):2635-41. PubMed ID: 20833868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of vibration perception thresholds obtained with the Neurothesiometer and the CASE IV and relationship to nerve conduction studies.
    Bril V; Perkins BA
    Diabet Med; 2002 Aug; 19(8):661-6. PubMed ID: 12147147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal vibration perception threshold alters the gait features in type 2 diabetes mellitus patients.
    Dong L; Hu Y; Xu L; Zeng H; Shen W; Esser P; Dawes H; Liu F
    Front Endocrinol (Lausanne); 2022; 13():1092764. PubMed ID: 36844372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability.
    van Deursen RW; Sanchez MM; Derr JA; Becker MB; Ulbrecht JS; Cavanagh PR
    Diabet Med; 2001 Jun; 18(6):469-75. PubMed ID: 11472466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.